Bicara Therapeutics Inc (BCAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BCAX | EYPT | ABCL | ||
| Company | Bicara Therapeutics Inc | Eyepoint Inc | Abcellera Biologics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 18.65 | 12.95 | 3.31 | ||
| High | 19.00 | 13.12 | 3.35 | ||
| Low | 18.05 | 12.44 | 3.24 | ||
| Latest | 18.37 | 12.50 | 3.27 | ||
| Change | -0.55 | -0.56 | -0.08 | ||
| % Change | -2.91% | -4.29% | -2.39% | ||
| Volume | 588,900 | 843,500 | 2,369,100 | ||
| 20-Day Average Volume | 572,835 | 1,297,230 | 2,672,645 | ||
| Previous Close | 18.92 | 13.06 | 3.35 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 18.80 | 14.57 | 3.51 | ||
| 20-Day Raw Stochastic | 54.48% | 6.32% | 5.03% | ||
| 20-Day Relative Strength | 53.33 | 38.56 | 43.98 | ||
| Weighted Alpha | +42.51 | +64.02 | +11.79 | ||
| Today's Opinion | 88% Buy | 40% Sell | 100% Sell | ||
| Previous Opinion | 100% Buy | 24% Sell | 96% Sell | ||
| Last Month's Opinion | 48% Buy | 72% Buy | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.22% since 03/20/26 | -5.52% since 03/20/26 | -3.82% since 03/20/26 | ||
| Low | 17.68 on 03/24/26 | 12.07 on 03/24/26 | 3.24 on 03/27/26 | ||
| High | 19.50 on 03/25/26 | 13.55 on 03/23/26 | 3.53 on 03/25/26 | ||
| 1-Month | |||||
| %Chg | +9.48% since 02/27/26 | -28.82% since 02/27/26 | -9.42% since 02/27/26 | ||
| Low | 16.12 on 03/02/26 | 12.07 on 03/24/26 | 3.24 on 03/27/26 | ||
| High | 20.25 on 03/11/26 | 18.87 on 03/02/26 | 3.84 on 03/02/26 | ||
| 3-Month | |||||
| %Chg | +9.35% since 12/26/25 | -31.66% since 12/26/25 | -8.66% since 12/26/25 | ||
| Low | 13.75 on 02/17/26 | 12.07 on 03/24/26 | 2.74 on 02/05/26 | ||
| High | 20.25 on 03/11/26 | 18.87 on 03/02/26 | 4.85 on 01/22/26 | ||
| 6-Month | |||||
| %Chg | +56.87% since 09/26/25 | -10.07% since 09/26/25 | -31.01% since 09/26/25 | ||
| Low | 11.81 on 09/29/25 | 9.65 on 11/05/25 | 2.74 on 02/05/26 | ||
| High | 20.25 on 03/11/26 | 19.11 on 12/08/25 | 6.51 on 10/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,006,345 | 1,042,900 | 991,333 | ||
| Shares Outstanding, K | 54,782 | 83,432 | 303,160 | ||
| Annual Sales | 0 | 31,370,000 | 75,130,000 | ||
| Annual Net Income | -68,000,000 | -231,960,000 | -146,410,000 | ||
| Last Quarter Sales | 0 | 620,000 | 44,850,000 | ||
| Last Quarter Net Income | -36,330,000 | -67,610,000 | -8,950,000 | ||
| 60-Month Beta | -0.78 | 1.72 | 0.84 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.67 on 11/10/25 | -0.81 on 03/04/26 | -0.03 on 02/24/26 | ||
| Latest Earnings Date | 03/30/26 | 05/06/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||